NZX company comparison

Compare NZX companies side by side

Select two or three covered companies to compare their latest source-backed financial metrics, reporting periods, and analytical context.

Tower (TWR)Heartland Group Holdings (HGH)General Capital (GEN)

Showing 3 companies.

← Swipe to view more

Company comparison table
Metric	TWR · HY26	HGH · HY26	GEN · FY26
Revenue	$291.2m	$172.3m	$26.8m
Revenue growth %	-1.6%	11.1%Outside range high revenue growth. 11.1%; 4-period range -2% to 10.2%. Revenue growth: 11.1%, above normal range; 4-period mean 6.8%, range -2.0%-10.2%.	18.2%
EBITDA	—	$77.9m	—
EBITDA margin %	—	45.2%	—
PBT	$32.2m	$68.1m	$4m
PBT growth %	-54.1%	—	2.6%
NPAT	$22.9m	$48.8m	$2.7m
NPAT growth %	-53.9%	n/mUnprecedented high npat growth. n/m; 4-period range -90.4% to 7.7%. NPAT growth: n/m, unprecedented high; 4-period mean -25.7%, range -90.4%-7.7%.	-3.6%Outside range low npat growth. -3.6%; 3-period range 7.7% to 73.7%. NPAT growth: -3.6%, below normal range; 3-period mean 32.2%, range 7.7%-73.7%.
Operating cash flow	$33m	$299.5m	-$24.6m
OCF / EBITDA %	—	384.7%	—
FCF pre-lease	—	—	-$24.6m
FCF post-lease	—	—	-$24.6m
DPS	5.0c	3.5c	0.8c
Payout ratio vs NPAT %	96.2%	67.3%Outside range low payout ratio versus npat. 67.3%; 4-period range 68.1% to 500%. Payout ratio versus NPAT: 67.3%, below normal range; 4-period mean 179.7%, range 68.1%-500.0%.	—

Source: latest published result for each selected company.

TWR vs HGH vs GEN comparison

Copy, export, or share this public comparison table.

Get new briefings that refresh this comparison when covered companies publish.